Empowering Health Professionals and Supporting Countries to Improve Immunization Program Performance

To address barriers to immunization, AMP teamed up with public- and private- partners in 2002 to develop and implement EpiVacPlus (formerly EPIVAC®). The program aims to enhance immunization program performance in Gavi-eligible African countries: Benin, Burkina Faso, Cameroon, Central African Republic, Côte d’Ivoire, Guinea, Mali, Mauritania, Niger, Senegal, and Togo.

Specific objectives are to strengthen the technical and managerial skills of the actors involved in immunization programs, and to improve the professional practices of these actors.

Partnering for Improved Immunization

EpiVacPlus was initiated in 2002 as a Sanofi Pasteur contribution to Gavi, the Vaccine Alliance. It was developed by AMP in partnership with governments of eligible countries, universities Félix Houphouët-Boigny and Paris-Dauphine, the World Health Organization (WHO), UNICEF, and other partners working in Africa.

Given the expansion of the program's scope in terms of field impact – reflected by the new name “EpiVacPlus” as of early 2013 – it now includes additional African partner universities and donors.


On-the-job training

Results-based performance

Translational research

EpiVac.net network

A Visible Impact on Immunization Program Performance

Between 2002 and 2012, EpiVacPlus trained 496 district medical officers in applied vaccinology and health management; 477 health professionals trained in field epidemiology; 77 in health promotion; and 34 in advocacy for immunization financing. Immunization program performance indicators show that districts with EpiVacPlus graduates are significantly better than those without.

Through more than 1,800 supervision reports and 470 operational research theses, crucial evidence has been collected on national immunization program performance, management, and funding at district level.

Rapport_3ème Conférence Technique EPIVAC.pdf839.34 KB
EPIVAC Poster_10 Years of Strengthening National EPI Performance.pdf1.91 MB